Alembic receives USFDA approval for Doxycycline Hyclate
Doxycycline Hyclate Delayed Release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria
Doxycycline Hyclate Delayed Release tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria
The company is focused on the development of novel treatments for RNA viruses
The tablets are indicated for the treatment of pulmonary arterial hypertension
The appraisal of the applications has been carried out based on the ranking methodology laid down in the operational guidelines of the Scheme
The ANDA has been co-developed in partnership with Orbicular Pharmaceutical Technologies
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
The cream has an estimated market size of US $ 28 million for twelve months ending Jun 2021 according to IQVIA
ICICI Direct gives an update on the 12 companies that it has covered in the healthcare universe. A report
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
Metronidazole Gel USP, 1% is indicated for the topical treatment of inflammatory lesions of rosacea
Subscribe To Our Newsletter & Stay Updated